Company Introduce: Sailong Pharmaceutical Group Co., Ltd. was established in 2002 and is a list pharmaceutical manufacturing company that integrates the research and development, production, sales, and technical services of intermediates, APIs, and pharmaceutical formulations. The company stock code is 002898. We have three main GMP production base, which is over 9000m2 production building including 7 APIs production lines and 1 intermediate production line. Covering the production of intermediate, active pharmaceutical ingredient and preparations. There are over 200 reactors used and have the abilities of Hydrogenation, chlorination, sulfonation, nitrification. We also have the technical advantage on “proton pump inhibitor” “chiral drugs” “slow release technology”
more >
Year of Establishment:
2002
Total Number of Staff:
500-1000
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
All
R&D capacity:
Annual Turnover(USD):
Other
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: